Literature DB >> 7893498

Retrospective analysis of the utility of video-assisted thoracic surgery in 100 consecutive procedures.

J P Hurley1, J McCarthy, A E Wood.   

Abstract

One hundred consecutive video-assisted thoracic surgery (VATS) procedures, diagnostic (n = 54) and therapeutic (n = 46), in 90 patients over a 2-year period are reviewed. Hospital mortality was 2%. Conversion to formal thoracotomy was required in 3%, and re-exploration for bleeding in 1%. Seven patients required intensive care unit facilities postoperatively. The technique described was safe and there was minimal postoperative morbidity. Diagnostic VATS was of particular use in cases of indeterminate pulmonary masses (Sensitivity of 96%), anterior mediastinal masses and in immunocompromised patients. Video-assisted thoracic surgery may now be the treatment of choice for recurrent pneumothoraces and it demonstrated potential for development in a variety of other benign thoracic disorders. This method had a limited role in the management of empyaema with a 60% conversion rate to formal thoracotomy. Pulmonary resections were feasible but its role in the treatment of malignancy is questioned.

Entities:  

Mesh:

Year:  1994        PMID: 7893498     DOI: 10.1016/1010-7940(94)90041-8

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  3 in total

1.  Video-assisted thoracic surgery (VATS) for spontaneous pneumothorax.

Authors:  J F McCarthy; D Lannon; S McKenna; A E Wood
Journal:  Ir J Med Sci       Date:  1997 Oct-Dec       Impact factor: 1.568

2.  One Stage Posterior Minimal Laminectomy and Video-Assisted Thoracoscopic Surgery (VATS) for Removal of Thoracic Dumbbell Tumor.

Authors:  Kyoung Hyup Nam; Hyo Yeoung Ahn; Jeong Su Cho; Yeoung Dae Kim; Byung Kwan Choi; In Ho Han
Journal:  J Korean Neurosurg Soc       Date:  2017-03-01

3.  Video-assisted thoracoscopic decortication for the management of late stage pleural empyema, is it feasible?

Authors:  Waseem M Hajjar; Iftikhar Ahmed; Sami A Al-Nassar; Rawan K Alsultan; Waad A Alwgait; Hanoof H Alkhalaf; Shekhar C Bisht
Journal:  Ann Thorac Med       Date:  2016 Jan-Mar       Impact factor: 2.219

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.